Biosimilars have the potential to change the way we think about, identify, and manage health problems. They are already impacting both clinical research and patient care, and this impact will only grow as our understanding and technologies improve. Written by a team of experienced specialists in clinical development, this book discusses various potential drug development strategies, the design and analysis of pharmacokinetics (PK) studies, and the design and analysis of efficacy studies.

This book constitutes the thoroughly refereed post-conference proceedings of the Third International ICST Conference on Forensic Applications and Techniques in Telecommunications, Information and Multimedia, E-Forensics 2010, held in Shanghai, China, in November 2010. The 32 revised full papers presented were carefully reviewed and selected from 42 submissions in total. These, along with 5 papers from a collocated workshop of E-Forensics Law, cover a wide range of topics including digital evidence handling, data carving, records tracing, device forensics, data tamper identification, and mobile device locating.

Biosimilars have the potential to change the way we think about, identify, and manage health problems. They are already impacting both clinical research and patient care, and this impact will only grow as our understanding and technologies improve. Written by a team of experienced specialists in clinical development, this book discusses various potential drug development strategies, the design and analysis of pharmacokinetics (PK) studies, and the design and analysis of efficacy studies.